Tofacitinib attenuates arthritis manifestations and reduces the pathogenic CD4 T cells in adjuvant arthritis rats

Copyright © 2017. Published by Elsevier Inc.

Détails bibliographiques
Publié dans:Clinical immunology (Orlando, Fla.). - 1999. - 184(2017) vom: 10. Nov., Seite 77-81
Auteur principal: Gertel, Smadar (Auteur)
Autres auteurs: Mahagna, Hussein, Karmon, Gidi, Watad, Abdulla, Amital, Howard
Format: Article en ligne
Langue:English
Publié: 2017
Accès à la collection:Clinical immunology (Orlando, Fla.)
Sujets:Journal Article Research Support, Non-U.S. Gov't Adjuvant induced arthritis (AIA) Pro-inflammatory cytokine IL-1β Th1 cells Tofacitinib Antirheumatic Agents IL1B protein, rat Interleukin-1beta Piperidines plus... Protein Kinase Inhibitors Pyrimidines Pyrroles RNA, Messenger Interferon-gamma 82115-62-6 tofacitinib 87LA6FU830 C-Reactive Protein 9007-41-4 Methotrexate YL5FZ2Y5U1